Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
Showing 26 - 50 of >10,000
Bariatric Surgery and Pharmacokinetics of Escitalopram
Recruiting
- Obesity, Morbid
-
Trondheim, NorwaySt. Olavs University Hospital
Mar 21, 2022
Bariatric Surgery and Pharmacokinetics of Chlorprothixene
Recruiting
- Obesity, Morbid
-
Trondheim, NorwaySt. Olavs University Hospital
Mar 14, 2022
Adenocarcinoma Gastric, Gastrooesophageal Cancer Trial in Worldwide (Ramucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701))
Recruiting
- Adenocarcinoma Gastric
- Gastrooesophageal Cancer
- Ramucirumab (CYRAMZA®)
- Tusamitamab ravtansine (SAR408701)
-
Bruxelles, Belgium
- +22 more
Jan 16, 2023
HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)
Not yet recruiting
- HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
- (no location specified)
Jan 3, 2023
Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)
Completed
- Gastric or Gastroesophageal Cancer
-
Kawasaki-shi, Kanagawa, Japan
- +1 more
Jun 13, 2023
Lactose Intolerance, Adult Type Trial in West Lafayette (Milk containing A1 and A2 beta-casein, Milk containing only A2
Active, not recruiting
- Lactose Intolerance, Adult Type
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
-
West Lafayette, IndianaPurdue MRI Facility
Dec 17, 2022
Orthodontic Pain Trial in Salt Lake City (Acetaminophen/Naproxen Sodium Fixed Combination)
Not yet recruiting
- Orthodontic Pain
- Acetaminophen/Naproxen Sodium Fixed Combination
-
Salt Lake City, UtahJBR Clinical Research LLP
Apr 25, 2023
Symptomatic Irreversible Pulpitis, Post Operative Pain Trial in Karachi (Tramadol, Naproxen Sodium, Placebo)
Recruiting
- Symptomatic Irreversible Pulpitis
- Post Operative Pain
- Tramadol
- +2 more
-
Karachi, Sindh, PakistanDow International Dental College
Aug 5, 2023
Pain Trial in Salt Lake City (Acetaminophen/naproxen sodium Dose A, Acetaminophen/naproxen sodium Dose B, Acetaminophen/naproxen
Completed
- Pain
- Acetaminophen/naproxen sodium Dose A
- +5 more
-
Salt Lake City, UtahJBR Clinical Research
Apr 6, 2022
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil
Recruiting
- Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
- 5-Fluorouracil (5-FU)
- +11 more
-
Scottsdale, Arizona
- +41 more
Jan 19, 2023
Gastric Assessment of Pediatric Patients Undergoing Surgery
Not yet recruiting
- Fasting
- +3 more
- Gastric Ultrasound Baseline Scans
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 5, 2023
Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)
Recruiting
- Serplulimab,Gastric Cancer, Adjuvant Therapy
- Serplulimab
- +2 more
-
Shanghai, ChinaZhang Zizhen
Mar 3, 2023
Advanced Solid Tumors Trial (ASKB589 Injection)
Not yet recruiting
- Advanced Solid Tumors
- ASKB589 Injection
- (no location specified)
Nov 21, 2022
Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)
Not yet recruiting
- Gastric Cancer
- +2 more
- TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- (no location specified)
Oct 16, 2023
Postoperative Dental Pain Trial in Salt Lake City (Naproxen sodium and caffeine (BAY2880376), Naproxen sodium (Aleve), Caffeine)
Not yet recruiting
- Postoperative Dental Pain
- Naproxen sodium and caffeine (BAY2880376)
- +3 more
-
Salt Lake City, UtahJBR Clinical Research
Aug 10, 2022
Acute Pain, Postoperative Pain Trial in Oaxaca (etoricoxib-tramadol, Naproxen, Tramadol)
Completed
- Acute Pain
- Postoperative Pain
- etoricoxib-tramadol
- +2 more
-
Oaxaca, MexicoOaxaca Site Management Organization
Aug 10, 2023
Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1
Active, not recruiting
- Gastric or Gastroesophageal Junction Adenocarcinoma
- neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Jul 4, 2023
Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))
Completed
- Gastric Cancer
- Arm I : Experimental (Prucalopride succinate group)
- Arm II : Control (Mosapride citrate group)
-
Seoul, Korea, Republic ofGangnamSeverance Hospital
Jul 21, 2023
Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)
Recruiting
- Gastric Cancer Stage IIIB-IIIC
- Pembrolizumab + SOX
-
Shanghai, Shanghai, ChinaRuijin Hospital
Sep 7, 2023
Epilepsy, Depression Trial in Rochester (Vagal nerve stimulant)
Not yet recruiting
- Epilepsy
- Depression
- Vagal nerve stimulant
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 14, 2023